Anticoagulation in Patients With Device‐Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial — Hans‐Christoph Diener (2024) | RDL Network
Anticoagulation in Patients With Device‐Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial
Article 2024 en
Authors
HD
Hans‐Christoph Diener
NB
Nina Becher
SS
Susanne Sehner
Abstract
1 min read
Anticoagulation appears to have ambiguous effects in patients with device-detected AF and a prior stroke or TIA in this hypothesis-generating analysis of the NOAH-AFNET 6 in the absence of ECG-documented AF, partially due to a low rate of stroke without anticoagulation.
Paulus Kirchhof, Tobias Toennis, Andreas Goette, A. John Camm, Hans‐Christoph Diener, Nina Becher, Emanuele Bertaglia, Carina Blomström Lundqvist, Martin Borlich, Axel Brandes, Nuno Cabanelas, Melanie Calvert, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Joris R. de Groot, Wolfgang Dichtl, Borys B. Kravchuk, Andrzej Lubiński, Éloi Marijon, Béla Merkely, Lluı́s Mont, Ann‐Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Douglas S. Scherr, Rafał Sznajder, Vasil Velchev, Dan Wichterle, Susanne Sehner, Εmmanuel Simantirakis, Professor Gregory Lip, Panos Vardas, Ulrich Schotten, Antonia Zapf
Discussion(0)
No comments yet. Be the first to comment.